ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 status

Zhang, Guochun; Ren, Chongyang; Li, Cheukfai; Wang, Yulei; Chen, Bo; Wen, Lingzhu; Jia, Minghan; Li, Kai; Mok, Hsiaopei; Cao, Li; Chen, Xiaoqing; Lin, Jiali; Wei, Guangnan; Li, Yingzhi; Zhang, Yuchen; Balch, Charles M.; Liao, Ning*广东省人民医院; 汕头大学
BMC Medicine2022-4-29DOI: 10.1186/s12916-022-02346-9
47被引11阅读
引用收藏
分享

摘要

Background HER2-low breast cancers were reported to have distinct clinicopathological characteristics from HER2-zero; however, the difference in their genetic features remains unclear. This study investigated the clinical and molecular features of breast tumors according to HER2 status. Methods We analyzed the clinicopathological and genomic data of 523 Chinese women with breast cancer. Genomic data was generated by targeted next-generation sequencing (NGS) of breast tumor samples using a commercial 520 gene panel. The cohort was stratified according to HER2 status as HER2-zero (n = 90), HER2-low (n = 231), and HER2-positive (n = 202) according to their immunohistochemistry and fluorescence in situ hybridization results. Results HER2-low breast tumors were enriched with hormone receptor-positive tumors, and who had lower Ki67 expression levels. Genes were differentially mutated across HER2 subgroups. HER2-low tumors had significantly more mutations involved in PI3K-Akt signaling than HER2-positive (p < 0.001) and HER2-zero breast tumors (p < 0.01). HER2-zero tumors had more mutations in checkpoint factors (p < 0.01), Fanconi anemia (p < 0.05), and p53 signaling and cell cycle pathway (p < 0.05) compared to HER2-low breast tumors. Compared with HER2-zero tumors, HER2-low tumors had significantly lower pathological complete response rates after neoadjuvant therapy (15.9% vs. 37.5%, p = 0.042) and proportion of relapsed/progressed patients across follow-up time points (p = 0.031), but had comparable disease-free survival (p = 0.271). Conclusion Our results demonstrate the distinct clinical and molecular features and clinical outcomes of HER2-low breast tumors.

学科与关键词

关键词
Breast cancerHuman epidermal growth factor receptor 2 (HER2)Genomic alterationHER2-lowNext-generation sequencing (NGS)Targeted therapy
相关
加载中…
  • Clinicopathological characteristics of HER2-low breast cancer: a retrospective study
    Yang, Man; Sun, Jiale; Liu, Liqiong; Kong, Xiangyi; Lin, Dongcai; Zhou, Hong; Gao, Jidong*Scientific Reports, 2023, 13(1): 12382.被引 3
  • Heterogeneity of genomic profile in patients with HER2-positive breast cancer
    Bo Chen; Zhang, Guochun; Wei, Guangnan; Wang, Yulei; Guo, Liping; Lin, Jiali; Kai Li; Mok, Hsiaopei; Li Cao; Ren, Chongyang; Wen, Lingzhu; Jia, Minghan; Li, Cheukfai; Ting Hou; Han Han-Zhang; Jing Liu; Balch, Charles M.; Ning Liao*Endocrine-Related Cancer, 2020, 27(3): 153-162.被引 22
  • Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy
    Li, Kai; Liao, Ning*; Chen, Bo; Zhang, Guochun; Wang, Yulei; Guo, Liping; Wei, Guangnan; Jia, Minghan; Wen, Lingzhu; Ren, Chongyang; Cao, Li; Mok, Hsiaopei; Li, Cheukfai; Lin, Jiali; Chen, Xiaoqing; Zhang, Zhou; Hou, Ting; Li, Min; Liu, Jing; Balch, Charles M.Breast Cancer Research and Treatment, 2020, 183(2): 321-332.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Medicine
发表日期
2022-04-29
卷期
第 20 卷, 第 1 期
页码
142
DOI
10.1186/s12916-022-02346-9
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2018A030313292]; Guangzhou Municipal Science and Technology Project [201804010430]; National Natural Science Foundation of China [81602645]; High-level Hospital Construction Project [DFJH201921]

作者

  • Z

    Zhang, Guochun (第一作者)

    guangdong prov peoples hosp

  • R

    Ren, Chongyang

    guangdong prov peoples hosp

查看全部 17 位作者收起作者
  • L

    Li, Cheukfai

    guangdong prov peoples hosp

  • W

    Wang, Yulei

    guangdong prov peoples hosp

  • C

    Chen, Bo

    guangdong prov peoples hosp

  • W

    Wen, Lingzhu

    guangdong prov peoples hosp

  • J

    Jia, Minghan

    guangdong prov peoples hosp

  • L

    Li, Kai

    guangdong prov peoples hosp

  • M

    Mok, Hsiaopei

    guangdong prov peoples hosp

  • C

    Cao, Li

    guangdong prov peoples hosp

  • C

    Chen, Xiaoqing

  • L

    Lin, Jiali

    guangdong prov peoples hosp

  • W

    Wei, Guangnan

    guangdong prov peoples hosp

  • L

    Li, Yingzhi

    guangdong prov peoples hosp · shantou univ

  • Z

    Zhang, Yuchen

    guangdong prov peoples hosp

  • B

    Balch, Charles M.

  • L

    Liao, Ning (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417